Off-Patent API Products

Pharma Solutions has developed a range of off-patent APIs for global markets. We have a presence in over 63 countries with an established network of distributors in several Asian, Latin American and EU countries. We supply leading Generic and big Pharma companies from our network of internationally compliant manufacturing sites across North America, the UK and India

---

We are the leading manufacturers for the following off-patent APIs:

Portfolio

Molecule	Indication(s)	DMF-CTD	CEP
Acyclovir	Anti-HIV
Amiodarone	Anti-arrhythmic
Camylofin	Anti-muscarinic
Diltiazem	Anti-hypertensive
dl-Cloprostenol Sodium	Luteolytic Agent
Ketoconazole	Anti-fungal
Mebeverine	Anti-spasmodic
Misoprostol	Anti-ulcerant
Monosulfiram	Ectoparacitide
Oxybutynin	Urinary Incontinence
Quetiapine	Anti-depressant
Sulindac	NSAID
Tramadol	Analgesic
Trazodone	Anti-depressant
Verapamil	Anti-hypertensive

---

We also continuously invest in the development of off-patent APIs that address some of the key diseases globally. The list of APIs under development for the US is as follows:

Molecule	Indication(s)
Aprepitant	Anti-emetic
Donepezil	Anti-Alzheimer’s
Emtricitabine	NRTI
Irbesartan	Anti-hypertensive
Sertraline	Anti-depressant
Telmisartan	Anti-hypertensive
Valacyclovir	Anti-viral

---